4565-full
relayman
Sex: M
Data Quality: 3 stars
Parkinson's: 9 yrs
Hoehn-Yahr 1 Type: Parkinson's disease On
Mouth/throat: none
Arms: none
Chest: none
Legs: none
relayman
Male, 68 years
Tucson, AZ
Primary Condition
Parkinson's
Type
Parkinson's disease
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

relayman's Stalevo 75 is for:

  • Parkinson's

relayman's side effects of Stalevo 75:

relayman's Stalevo 75 History (Stopped)
Stalevo 75 (carbidopa-entacapone-levodopa)
50 mg Daily Nov 01 - Dec 01, 2009
225 mg Daily Dec 01 - 13, 2009
Stopped Side effects too severe Dec 13, 2009
Evaluations
Date Dosage Parkinson's Disease Perceived effectiveness Side Effects Adherence Burden
Dec 13, 2009 225 mg Daily Led_efficacy_2Led_efficacy_2Led_defaultLed_default ModerateModerateModerateModerate AlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at all
Date
Dec 13, 2009
Advice & Tips
At this time the side effects (loss of appetite, dizzyness and drymouth) outweighed the benefits (better arm swing and reduction of leg tremor). I will wait until the benefits are greater. I am doing well with structured exercise classes specifically designed for PD patients.
Cost
< $25 monthly

About Stalevo 75 (Prescription Drug)

Stalevo® 75 is a brand name for a combination of the drugs Levodopa 75 mg, carbidopa 18.75 mg, and entacapone 200 mg. Levodopa is the precursor to dopamine, carbidopa slows the breakdown of levodopa, while entacapone improves the efficacy of levodopa.

Learn more about Stalevo 75 in our Stalevo 75 Community Report.

Back to relayman's Profile